194 related articles for article (PubMed ID: 8356307)
1. [Recombinant granulocyte colony-stimulating factor in the long-term treatment of AIDS-related neutropenias].
Garavelli PL; Berti P
Recenti Prog Med; 1993; 84(7-8):526-30. PubMed ID: 8356307
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte-macrophage colony-stimulating factor and zidovudine in the treatment of neutropenia and human immunodeficiency virus infection.
Hewitt RG; Morse GD
Pharmacotherapy; 1992; 12(6):455-61. PubMed ID: 1492010
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of granulocyte colony-stimulating factor (G-CSF) on neutropenia in zidovudine-treated patients with AIDS and ARC: a preliminary report.
Garavelli PL
Haematologica; 1992; 77(3):293-4. PubMed ID: 1385275
[No Abstract] [Full Text] [Related]
4. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
Wong SF; Chan HO
Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human granulocyte-macrophage colony-stimulating factor ameliorates zidovudine-induced neutropenia in patients with acquired immunodeficiency syndrome (AIDS)/AIDS-related complex.
Levine JD; Allan JD; Tessitore JH; Falcone N; Galasso F; Israel RJ; Groopman JE
Blood; 1991 Dec; 78(12):3148-54. PubMed ID: 1742482
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of neutropenia in HIV infection with hematopoietic growth factors].
Moreno García M; Fernández González F
Rev Clin Esp; 1996 Apr; 196(4):248-54. PubMed ID: 8701065
[No Abstract] [Full Text] [Related]
7. Haematopoietic growth factors as supportive therapy in HIV-infected patients.
Hermans P
AIDS; 1995 Dec; 9 Suppl 2():S9-S14. PubMed ID: 8775801
[TBL] [Abstract][Full Text] [Related]
8. [The effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) on childhood neutropenias].
Ueda K; Hanawa Y; Takaku F; Asano S; Tsukimoto I; Tsuchida M; Sato T; Ohira M; Hoshi Y; Nishihira K
Rinsho Ketsueki; 1991 Mar; 32(3):212-20. PubMed ID: 1710294
[TBL] [Abstract][Full Text] [Related]
9. AIDS Clinical Trials Group Study 094: a phase I/II trial of ABV chemotherapy with zidovudine and recombinant human GM-CSF in AIDS-related Kaposi's sarcoma.
Gill PS; Mitsuyasu RT; Montgomery T; Huang J; Cabriales S; Testa M; Espina BM; Levine AM; Miles SA
Cancer J Sci Am; 1997; 3(5):278-83. PubMed ID: 9327151
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte colony-stimulating factors.
Med Lett Drugs Ther; 1991 Jun; 33(847):61-3. PubMed ID: 1710761
[No Abstract] [Full Text] [Related]
11. Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine.
Miles SA; Mitsuyasu RT; Moreno J; Baldwin G; Alton NK; Souza L; Glaspy JA
Blood; 1991 May; 77(10):2109-17. PubMed ID: 1709368
[TBL] [Abstract][Full Text] [Related]
12. G-CSF in the long-term treatment of cyclic neutropenia and chronic idiopathic neutropenia in adult patients.
Heussner P; Haase D; Kanz L; Fonatsch C; Welte K; Freund M
Int J Hematol; 1995 Dec; 62(4):225-34. PubMed ID: 8589368
[TBL] [Abstract][Full Text] [Related]
13. The use of hematopoietic hormones in HIV infection and AIDS-related malignancies.
Miles SA; Golde DW; Mitsuyasu RT
Hematol Oncol Clin North Am; 1991 Apr; 5(2):267-80. PubMed ID: 2022593
[TBL] [Abstract][Full Text] [Related]
14. A randomized, placebo-controlled trial of granulocyte-macrophage colony-stimulating factor and nucleoside analogue therapy in AIDS.
Brites C; Gilbert MJ; Pedral-Sampaio D; Bahia F; Pedroso C; Alcantara AP; Sasaki MD; Matos J; Renjifo B; Essex M; Whitmore JB; Agosti JM; Badaro R
J Infect Dis; 2000 Nov; 182(5):1531-5. PubMed ID: 11023477
[TBL] [Abstract][Full Text] [Related]
15. The use of growth hematopoietic factors in AIDS.
Groopman JE
Pathol Biol (Paris); 1992 Nov; 39(9):874-5. PubMed ID: 1371606
[No Abstract] [Full Text] [Related]
16. In vivo effects of recombinant human granulocyte-macrophage colony-stimulating factor (rHuGM-CSF), alone and associated with zidovudine, on HIV-1 replication.
Manfredi R; Re MC; Furlini G; Gorini R; Chiodo F
New Microbiol; 1997 Oct; 20(4):345-50. PubMed ID: 9385605
[TBL] [Abstract][Full Text] [Related]
17. Combination of ganciclovir and granulocyte-macrophage colony-stimulating factor in the treatment of cytomegalovirus retinitis in AIDS patients. The ACTG 073 Team.
Hardy D; Spector S; Polsky B; Crumpacker C; van der Horst C; Holland G; Freeman W; Heinemann MH; Sharuk G; Klystra J
Eur J Clin Microbiol Infect Dis; 1994; 13 Suppl 2():S34-40. PubMed ID: 7875151
[TBL] [Abstract][Full Text] [Related]
18. Neutropenia, neutrophil dysfunction, and bacterial infection in patients with human immunodeficiency virus disease: the role of granulocyte colony-stimulating factor.
Kuritzkes DR
Clin Infect Dis; 2000 Feb; 30(2):256-60. PubMed ID: 10671324
[TBL] [Abstract][Full Text] [Related]
19. Interferon-alpha, zidovudine, and granulocyte-macrophage colony-stimulating factor: a phase I AIDS Clinical Trials Group study in patients with Kaposi's sarcoma associated with AIDS.
Krown SE; Paredes J; Bundow D; Polsky B; Gold JW; Flomenberg N
J Clin Oncol; 1992 Aug; 10(8):1344-51. PubMed ID: 1634925
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
Root RK; Dale DC
J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
